The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Hafnium oxide nanoparticles activated by SABR in combination with PD-1 inhibitors for the treatment of patients with advanced HNSCC or NSCLC: A phase I/II trial.
 
Tanguy Y. Seiwert
Honoraria - AstraZeneca; Bristol-Myers Squibb; Merck
Consulting or Advisory Role - Aduro Biotech; AstraZeneca; Bayer; Bristol-Myers Squibb; Celgene; Innate Pharma; Merck; Nanobiotix; Roche Molecular Diagnostics
Research Funding - Bristol-Myers Squibb (Inst); Jounce Therapeutics (Inst); Merck (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Bristol-Myers Squibb; Celgene; Innate Pharma; Merck; Nanobiotix; Roche Molecular Diagnostics
 
Corey Christian Foster
No Relationships to Disclose
 
Christophe Le Tourneau
Honoraria - Bristol-Myers Squibb; Novartis
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Merck Serono; MSD
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; MSD
 
Valentin Calugaru
Consulting or Advisory Role - Nanobiotix
 
Sylvie Bonvalot
Consulting or Advisory Role - Nanobiotix